1 Min Read
June 28 (Reuters) - Cadila Healthcare Ltd:
* Says Zydus receives final approval from USFDA for oxybutynin chloride extended-release tablets Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.